Page last updated: 2024-08-23

diltiazem and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

diltiazem has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, JS; Han, HK; Piao, YJ	1
Li, Q; Li, X; Sun, X; Wu, Z; Yang, H; Yang, J; Zhang, X; Zhao, J	1
Alpa, M; Cravedi, P; Daina, E; Gamba, S; Gaspari, F; Perna, A; Remuzzi, G; Roccatello, D; Ruggenenti, P	1

Trials

1 trial(s) available for diltiazem and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

Article	Year
Effects of combination of statin and calcium channel blocker in patients with cardiac syndrome X. Coronary artery disease, 2014, Volume: 25, Issue:1 Topics: Calcium Channel Blockers; China; Coronary Circulation; Coronary Vessels; Diltiazem; Drug Therapy, Combination; Endothelin-1; Exercise Tolerance; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Male; Microvascular Angina; Middle Aged; Nitric Oxide; Prospective Studies; Time Factors; Treatment Outcome	2014

Article

Year

Effects of combination of statin and calcium channel blocker in patients with cardiac syndrome X.

Coronary artery disease, 2014, Volume: 25, Issue:1

Topics: Calcium Channel Blockers; China; Coronary Circulation; Coronary Vessels; Diltiazem; Drug Therapy, Combination; Endothelin-1; Exercise Tolerance; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Male; Microvascular Angina; Middle Aged; Nitric Oxide; Prospective Studies; Time Factors; Treatment Outcome

2014

Other Studies

2 other study(ies) available for diltiazem and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

Article	Year
Pharmacokinetic interaction between fluvastatin and diltiazem in rats. Biopharmaceutics & drug disposition, 2006, Volume: 27, Issue:9 Topics: Animals; Area Under Curve; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Diltiazem; Drug Interactions; Fatty Acids, Monounsaturated; Fluvastatin; Indoles; Male; Rats; Rats, Sprague-Dawley	2006
A multidrug, antiproteinuric approach to alport syndrome: a ten-year cohort study. Nephron, 2015, Volume: 130, Issue:1 Topics: Adult; Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Calcium Channel Blockers; Cohort Studies; Diltiazem; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fluvastatin; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Kidney Function Tests; Male; Middle Aged; Nephritis, Hereditary; Prospective Studies; Proteinuria; Valsartan	2015

Article

Year

Pharmacokinetic interaction between fluvastatin and diltiazem in rats.

Biopharmaceutics & drug disposition, 2006, Volume: 27, Issue:9

Topics: Animals; Area Under Curve; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Diltiazem; Drug Interactions; Fatty Acids, Monounsaturated; Fluvastatin; Indoles; Male; Rats; Rats, Sprague-Dawley

2006

A multidrug, antiproteinuric approach to alport syndrome: a ten-year cohort study.

Nephron, 2015, Volume: 130, Issue:1

Topics: Adult; Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Calcium Channel Blockers; Cohort Studies; Diltiazem; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fluvastatin; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Kidney Function Tests; Male; Middle Aged; Nephritis, Hereditary; Prospective Studies; Proteinuria; Valsartan

2015